Therapeutic regimen comprising peginterferon, ribavirin and VX-950 for the treatment of Hepatitis "
Details for Australian Patent Application No. 2009296653 (hide)
International Classifications
Event Publications
28 April 2011 PCT application entered the National Phase
PCT publication WO2010/036799 Priority application(s): WO2010/036799
26 May 2011 Alteration of Name
The name of the applicant has been altered to Jassen Pharmaceutica NV; Vertex Pharmaceuticals Incorporated 2010
9 June 2011 Corrigenda
Change of Names(s) of Applicant(s), Section 104 - 2009 Under the Name Jassen Pharmaceutica NV, Application No. 2009296653, under INID (71) correct the applicant name to Janssen Pharmaceutica NV
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009296656-Pollution control system
2009296645-Hip and knee actuation systems for lower limb orthotic devices
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser